Enabling the Immune Escaped Etesevimab Fully-Armed Against SARS-CoV-2 Omicron Subvariants Including KP.2
hLife(2025)
关键词
etesevimab (CB6),severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),receptor-binding domain (RBD),broad-spectrum and affinity-mature antibody design (BAADesign),antibody
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要